Lepu Medical Technology (Beijing) Co., Ltd. (SWX:LEPU)
Switzerland flag Switzerland · Delayed Price · Currency is CHF · Price in USD
18.00
0.00 (0.00%)
At close: Jan 28, 2026

SWX:LEPU Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Operating Revenue
6,2126,0597,91610,55310,6137,992
Other Revenue
44.244.264.2456.9346.7446.61
6,2576,1037,98010,60910,6608,039
Revenue Growth (YoY)
-3.84%-23.52%-24.79%-0.47%32.61%3.12%
Cost of Revenue
2,5432,5562,9824,0214,1662,660
Gross Profit
3,7133,5474,9986,5886,4945,378
Selling, General & Admin
2,0802,2362,4402,7762,8582,445
Research & Development
806.71769.56879.42957.06907.94736.13
Other Operating Expenses
11.8363.2858.3733.9103.1482.56
Operating Expenses
2,9513,1193,4043,7933,8823,303
Operating Income
761.72427.991,5942,7952,6122,076
Interest Expense
-186.55-181-170.65-188.78-228.49-268.92
Interest & Investment Income
96.25115.51115.3487.9957.5943.16
Currency Exchange Gain (Loss)
26.9126.91-25.3816.146.58-26.96
Other Non Operating Income (Expenses)
-48.91-9.43-4.22-25.77-79.03-23.96
EBT Excluding Unusual Items
649.43379.991,5092,6842,3681,799
Impairment of Goodwill
-62.95-62.95-33.45---
Gain (Loss) on Sale of Investments
-101.79-89.32-13.44-70.91-367.54298.06
Gain (Loss) on Sale of Assets
-1.1511.73-4.070.0219.92.29
Asset Writedown
-53.19-65.5-6.93-1.72-2.39-16.99
Other Unusual Items
51.8151.81103.55-127.71121.03
Pretax Income
482.17225.761,5542,6122,1462,203
Income Tax Expense
72.2328.47262.15365.73365.73326.23
Earnings From Continuing Operations
409.94197.291,2922,2461,7801,877
Minority Interest in Earnings
16.3949.64-34.15-42.28-61.09-75.15
Net Income
426.33246.941,2582,2041,7191,802
Net Income to Common
426.33246.941,2582,2041,7191,802
Net Income Growth
-39.72%-80.37%-42.91%28.18%-4.58%4.44%
Shares Outstanding (Basic)
1,8441,8481,8621,8021,7921,777
Shares Outstanding (Diluted)
1,8441,8481,8621,8171,8081,777
Shares Change (YoY)
-0.49%-0.74%2.48%0.50%1.75%0.37%
EPS (Basic)
0.230.130.681.220.961.01
EPS (Diluted)
0.230.130.681.210.951.01
EPS Growth
-39.42%-80.23%-44.29%27.54%-6.22%4.05%
Free Cash Flow
718.5275.82145.691,8852,0781,490
Free Cash Flow Per Share
0.390.040.081.041.150.84
Dividend Per Share
0.2980.2770.3310.3410.2750.228
Dividend Growth
-37.10%-16.42%-2.81%24.00%20.61%14.00%
Gross Margin
59.35%58.12%62.63%62.10%60.92%66.91%
Operating Margin
12.17%7.01%19.97%26.34%24.50%25.82%
Profit Margin
6.81%4.05%15.77%20.77%16.13%22.42%
Free Cash Flow Margin
11.48%1.24%1.83%17.77%19.49%18.53%
EBITDA
1,300927.052,0403,2053,0042,464
EBITDA Margin
20.78%15.19%25.57%30.21%28.18%30.65%
D&A For EBITDA
538.3499.06446.75410.11392.37388.21
EBIT
761.72427.991,5942,7952,6122,076
EBIT Margin
12.17%7.01%19.97%26.34%24.50%25.82%
Effective Tax Rate
14.98%12.61%16.86%14.00%17.04%14.81%
Revenue as Reported
6,2576,1037,98010,60910,6608,039
Advertising Expenses
-28.4984.2360.0876.0476.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.